Postural Sway and Counterpressure Maneuvers for Pediatric Syncope
Impact of Postural Sway on Cardiovascular Control in Pediatric Patients With Syncope
Simon Fraser University
30 participants
Apr 17, 2023
INTERVENTIONAL
Conditions
Summary
The investigators are interested in whether discrete counterpressure maneuvers, or muscle movements in the lower body, will boost blood pressure and cardiovascular control in children who faint. We will record cardiovascular responses to maneuvers of exaggerated sway, leg crossing, crouching, and gluteal muscle tensing in children who faint (N=20), as well as their height, weight, muscularity, and pubertal (Tanner) stage. Autonomic cardiovascular control will be measured using a Valsalva manoeuvre (expiration against a closed airway for 20 seconds) and a supine-stand test. The primary outcomes are noninvasive measures of cardiovascular responses to the maneuvers (blood pressure, cerebral blood flow, and stroke volume (volume of blood pumped per heartbeat). Comparisons will be made across levels of sex, diagnosis, Tanner stage, muscularity, height, and degree of autonomic control.
Eligibility
Inclusion Criteria1
- We are looking for English speaking pediatric patients aged 6-18 years with a diagnosis of recurrent fainting (at least two episodes of fainting with loss of consciousness or near loss of consciousness in the last year) of a vasovagal origin or associated with the postural orthostatic tachycardia syndrome (POTS) (as determined by a paediatric cardiologist) to take part in this study.
Exclusion Criteria12
- Those with a diagnosis of recurrent fainting accompanied by any of the following will not be eligible to take part:
- Known history of:
- Suspected or confirmed cardiac arrhythmia (e.g., Wolff-Parkinson-White, Long QT)
- Traumatic head injury
- New presentation of a seizure disorder OR epilepsy recurrence
- Overdose or intoxication
- Structural heart disease
- Cardiovascular disease including hypertension, diabetes, or renal disease
- Hypoglycemia
- Physical and/or psychological disability that impact their ability to complete the tests
- Female participants of childbearing age will be excluded if they are pregnant, or think they might be. Participants who are taking any cardiovascular acting medications, including treatment for cardiovascular disease, or medications for orthostatic syncope (e.g. fludrocortisone, slow-release sodium chloride, β-blockers, midodrine) will be excluded from the study.
- In order to reduce the likelihood of transmission of COVID-19, participants will only be eligible to participate in the study if they have received full immunisation against COVID-19 according to current Health Canada guidelines. Accordingly, participants will be asked to provide evidence of their vaccination status in order to take part in the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Movements that can aid in delaying or preventing syncope by recruiting skeletal muscle pumping (via compression of major veins by contracting muscle to eject blood through cardiovascular circuit) and increased sympathetic drive (via sustaining an isometric muscle contraction). In this trial, we will be evaluating two clinically recommended isometric maneuvers (crouching, and leg crossing with muscle tensing) and two novel dynamic maneuvers that comprise discrete movement that the investigators have identified in prior work (exaggerated anterior-posterior postural sway, rhythmic gluteal clenching).
Participants will stand quietly for 5-minutes on a force platform to allow the investigators to assess their typical response to orthostasis.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05633693